Atlas Trials

Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Clinical trial NCT02353468 · TERMINATED

Trial details

NCT number
NCT02353468
Sponsor
University of Colorado, Denver
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Plasma Cell Myeloma
Start date
2009-12-01
Primary completion
2011-10-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.